Fig. 4From: Functional insights from targeted imaging BACE1: the first near-infrared fluorescent probe for Alzheimer’s disease diagnosisHBAE and BACE1 specific antibody (Alex fluo 488) followed by the treatment with fluorescently (Alex fluo 488) labeled secondary antibody. Scale bar = 10 μmBack to article page